Last updated: October 27, 2020
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Dementia
Mild Cognitive Impairment
Memory Loss
Treatment
N/AClinical Study ID
NCT04133714
2019-313
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 18-60 year-old
- diagnosed cerebral apoplexy, meeting the diagnostic criteria of ICD-10
- cognitive function, perceptual function decline after stroke
- first onset and duration of 3-12 months
- right-handed
- MMSE ≤25
- MoCA ≤25
- sign informed consent voluntarily and comply with the study plan
Exclusion
Exclusion Criteria:
- NIHSS ≥21 points
- MoCA ≤18, or DRS-2 ≤ 124, or CES-D ≥ 16
- taking drugs that affect central nervous activity, such as nerve antagonists
- specific contraindication, such as electrode patch allergy, local skin injury or - - -
- inflammation, and hyperalgesia in stimulated areas
- patients use implantable electronic devices (such as cardiac pacemakers) or have -metal implants such as stents that affect MRI examination
- patients with a previous history of epilepsy, mental illness or skull injury
- patients with dementia or obvious cognitive dysfunction before stroke
- patients with aphasia or dysarthria and cannot complete the scale evaluation
- pregnancy
Study Design
Total Participants: 180
Study Start date:
November 01, 2020
Estimated Completion Date:
December 31, 2023
Connect with a study center
Rainbowfish Rehabilitation Nursing Care
Hangzhou, Zhejiang 310000
ChinaActive - Recruiting
SAHZhejiangU
Hangzhou, Zhejiang 310009
ChinaActive - Recruiting
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang 310014
ChinaActive - Recruiting
Southwest Hospital
Chongqing, 400000
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.